Betsy L. Meredith Elswick, Pharm.D.
Clinical Associate Professor Director, WVU-Rite Aid Community Pharmacy Practice Residency
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
1124 Health Sciences North
P.O. Box 9520
Morgantown, WV 26506-9520
Link to Full CV - PDF
Betsy Meredith Elswick, PharmD, is a Clinical Associate Professor in the Department of Clinical Pharmacy at the West Virginia University School of Pharmacy and Director of the WVU-Rite Aid Community Pharmacy Practice Residency. Dr. Elswick currently serves as co-chairperson for the Wigner Institute for Advanced Pharmacy Practice, Education and Research, an institute committed to advancing the role of the community pharmacist in West Virginia. She is a graduate of the WVU School of Pharmacy and completed a Pharmacy Practice Residency at Virginia Commonwealth University in Richmond, VA. Her current practice site, located in a Rite Aid Pharmacy in Grafton, WV, was the first community pharmacy in West Virginia to receive status from the American Diabetes Association as a Recognized Program. In 2008, she was appointed to an ad hoc committee for the West Virginia Board of Pharmacy to finalize the rules to allow pharmacists to immunize in West Virginia. Dr. Elswick serves as program faculty for the American Pharmacists Association immunization certificate program and has trained over 200 pharmacists to provide adult immunizations in West Virginia. Dr. Elswick is a member of the WVU School of Pharmacy’s Weapons of Mass Destruction Task Force. She currently serves as President for the West Virginia Pharmacists Association. Dr. Elswick’s past accomplishments include receiving the 2005 Innovative Pharmacy Practice Award, the 2006 WV Distinguished Young Pharmacist Award, and a 2007 Outstanding Teaching Award from the WVU School of Pharmacy P-1 students. She is also the recipient of a 2007 Health Care Heroes award by the State Journal and was named to the Lincoln High School Hall of Fame in 2009. Her areas of research interest include diabetes, rural health, and the role of the community pharmacist in advanced patient care activities, including immunization delivery.
PHAR 793: Pharmacy Advocacy and Leadership (2 Credit hour professional elective); Course coordinator, lecturer
PHAR 762: Ambulatory Care Clerkship (4 Credit hours); Primary preceptor (Currently offers 5, 4-week rotations; total of 5 students annually)
PHAR 720: Patient Health Education (2 Credit hours); Course coordinator, lecturer
PHAR 703: Practicum I: Introduction to Pharmacy Practice Experience (1 Credit hour); Course co-coordinator (2005-09), lecturer
PHAR 710: Practicum II: Introduction to Pharmacy Practice Experience II (1 Credit hour); Course co-coordinator (2006-09), lecturer
PHAR 701: Pharmaceutical Care Lab I (2 Credit hours); Lab instructor
PHAR 724, 724 W: Pharmaceutical Care Lab IV (writing course and pre-lab) (2 Credit hours); Lab instructor
PHAR 736: Pharmaceutical Care Lab VI (1 Credit hour); Lab instructor
PHAR 739: Therapeutic Patient Monitoring (3 Credit hours); Lecturer
PHAR 737: Disease Prevention and Health Promotion (2 Credit hours); Lecturer
OTHER WEST VIRGINIA UNIVERSITY ACADEMIC TEACHING INSTRUCTION:
ATTR 650: Medical and Surgical Aspects of Athletic Training; Lecturer
Weitzman A, McDowell K, Elswick B, Blommel M. Consumer Perception of Pharmacist’s Role in Diabetes: Results of Operation Diabetes Initiative. JAPhA. 2009; 49(6): 716-721.
Blake KB, Madhavan SS, Scott VG, Elswick B. Medication therapy management services in West Virginia: Pharmacist’s perceptions of educational and training needs. Research in Social and Administrative Pharmacy 2009; 5:182-188.
Sundaram M, Smith MJ, Revicki DA, Elswick B, Miller LA. Rasch analysis informed the development of a classification system for a diabetes-specific preference-based measure of health. J Clin Epidemiol. 2009; 62(8):845-56.
Kavookjian J, Elswick B, Whetsel T. Interventions for being active among individuals with diabetes: a systematic review of the literature. The Diabetes Educator. 2007; 33(6):962-988.
Whetsel T, Elswick B. Update for pharmacists: 2007 ADA standards of medical care in diabetes. Pharmacy Today. 2007; 13(4):47-63.
Elswick B, Mitrzyk BM. Diabetes 2006: An update for pharmacists. Pharmacy Today. 2006; 12(10): 47-60.
Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Annals of Pharmacotherapy. 2006 Apr; 40(4):605-11.
Thompson JB, Meredith BL, Jacknowitz AI. Use of dietary supplements in ambulatory rural patients with diabetes and without diabetes. JAPhA. 2004; 44(6):718-720.
Erdogan ON, Meredith BL. Pharmacy services in Turkey: yesterday, today, and tomorrow. Am J Health Syst Pharm. 2004; 61(3):293-7.
Meredith BL, Cupp MJ, Tracy, TS. Gamma-Hydroxybutyric acid (GBL), Gamma-Butyrolactone (GBL), and 1,4-Butanediol (BD), In: Dietary Supplements: Toxicology and Clinical Pharmacology. Cupp, M.J., and Tracy, T.S., Eds., Humana Press: Totowa, N.J, 2002.
American Society fo Health System Pharmacists (ASHP) Foundation. Innovative Pharmacist-Led Strategies to Promote Health Care Worker Influenza Immunization. Co-Principal Investigators: Betsy Elswick and Diana Vinh. $25,000 for direct and indirect costs. 2010-2011.
American Pharmacists Association Foundation. Incentive Grant for Outcomes Associated With Implementing Diabetes Conversation Maps in a Community Pharmacist Directed Diabetes Education Program. Principal Investigator: Betsy Elswick. Co-Investigator: Erica Hutton. $1000 for direct costs. 2008-2009.
American Pharmacists Association Foundation. Incentive Grant for Practitioner Innovation in Pharmaceutical Care. Promoting colorectal cancer awareness and screening in a rural community pharmacy setting. Principal Investigator: Dani Dolin (resident). Co-Investigator: Betsy Meredith. $1000 for direct costs. 2003-2004.
Institute for the Advancement of Community Pharmacy. Grant for Community Pharmacy Practice Residency Funding. Primary applicant: Betsy Elswick. $15,000 for indirect costs. 2003-2004 residency years.